Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Heparin-induced thrombocytopenia].

K Gürtler1, I Euchner-Wamser, G Neeser

  • 1Klinik für Anästhesiologie und Operative Intensivmedizin, Klinikum Augsburg, 86156 , Augsburg, Germany. karlheinz.guertler@klinikum-augsburg.de

Der Anaesthesist
|September 1, 2006
PubMed
Summary

Heparin-induced thrombocytopenia type II (HIT type II) is a dangerous immune side effect of anticoagulant therapy, causing dangerous blood clots. Diagnosis and management are critical, especially in surgery patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[82 years old, male high-risk cardiac patient to planned Y-prosthesis implantation for abdominal aortic aneurysm : Preparation for the medical specialist examination: part 38].

Der Anaesthesist·2019
Same author

[70-year-old male with more than 40 pack years scheduled for implant removal : Preparation for the medical specialist examination: Part 1].

Der Anaesthesist·2019
Same author

[New oral anticoagulants in perioperative medicine].

Der Anaesthesist·2014
Same author

[Awake fiberoptic intubation].

Der Anaesthesist·2011
Same author

[Organ donation].

Der Anaesthesist·2007
Same author

Correlation of MMSE, SKT and clock test scores in patients with mild and moderate dementia.

Nagoya journal of medical science·2007

Area of Science:

  • Hematology
  • Immunology
  • Pharmacology

Background:

  • Heparins are widely used anticoagulants for preventing and treating thromboembolisms.
  • A serious adverse effect is heparin-induced thrombocytopenia type II (HIT type II), an immune condition causing paradoxical thromboembolic occlusions.
  • HIT type II involves platelet activation and plasma coagulation, leading to acute thrombocytopenia.

Purpose of the Study:

  • To review the diagnosis and differential diagnosis of HIT type II.
  • To emphasize diagnostic challenges in postoperative intensive care patients.
  • To discuss preventive measures and management strategies for HIT type II and associated thrombotic complications.

Main Methods:

  • Literature review of heparin-induced thrombocytopenia type II.
  • Analysis of diagnostic criteria and differential diagnoses.
  • Discussion of clinical management and prevention strategies.

Main Results:

  • HIT type II presents as acute thrombocytopenia (platelet count <50% of baseline) 5-14 days after heparin initiation.
  • Thromboembolic complications (venous and arterial) are common.
  • Postoperative patients exhibit higher rates of subclinical antibody formation and symptomatic HIT type II.

Conclusions:

  • Accurate and timely diagnosis of HIT type II is challenging, particularly in intensive care settings.
  • Early recognition and appropriate management are crucial to prevent severe thrombotic events.
  • Preventive strategies and alternative anticoagulation are essential for at-risk patients.

Related Experiment Videos